Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
Submitted by
admin
on May 22, 2017 - 9:43am
Source:
RAPS.org
News Tags:
FDA
Kalydeco
cystic fibrosis
Headline:
FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
Do Not Allow Advertisers to Use My Personal information
